Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Total Liabilities

Latest as of September 2025: CN¥1.62 Billion CNY ≈ $236.76 Million USD

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has total liabilities worth CN¥1.62 Billion CNY (≈ $236.76 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see 002390 asset base.

Guizhou Xinbang Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 002390 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Niutech Environment Technology Corp SHG:688309	China	CN¥189.23 Million
SG Fleet Group Ltd AU:SGF	Australia	AU$2.91 Billion
Guangdong Lvtong New Energy Electric Vehicle Technology Co. Ltd. Cl A SHE:301322	China	CN¥937.50 Million
Scandinavian Tobacco Group A/S CO:STG	Denmark	Dkr7.67 Billion
PWR Holdings Ltd AU:PWH	Australia	AU$106.77 Million
Shenzhen Feima International Supply Chain Co Ltd SHE:002210	China	CN¥455.01 Million
DBV Technologies S.A. PA:DBV	France	€58.50 Million
S.J.S. Enterprises Limited NSE:SJS	India	Rs2.31 Billion

Liability Composition Analysis (2006–2024)

This chart breaks down Guizhou Xinbang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check Guizhou Xinbang Pharmaceutical Co Ltd (002390) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guizhou Xinbang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total liabilities of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥2.01 Billion ≈ $293.89 Million	-4.49%
2023-12-31	CN¥2.10 Billion ≈ $307.72 Million	-22.92%
2022-12-31	CN¥2.73 Billion ≈ $399.20 Million	-2.57%
2021-12-31	CN¥2.80 Billion ≈ $409.75 Million	-37.69%
2020-12-31	CN¥4.49 Billion ≈ $657.57 Million	-16.34%
2019-12-31	CN¥5.37 Billion ≈ $785.96 Million	-5.54%
2018-12-31	CN¥5.69 Billion ≈ $832.01 Million	+9.42%
2017-12-31	CN¥5.20 Billion ≈ $760.38 Million	+20.51%
2016-12-31	CN¥4.31 Billion ≈ $630.99 Million	+12.41%
2015-12-31	CN¥3.84 Billion ≈ $561.31 Million	+38.71%
2014-12-31	CN¥2.77 Billion ≈ $404.66 Million	+513.59%
2013-12-31	CN¥450.69 Million ≈ $65.95 Million	+44.46%
2012-12-31	CN¥311.99 Million ≈ $45.65 Million	+18.17%
2011-12-31	CN¥264.02 Million ≈ $38.63 Million	+59.23%
2010-12-31	CN¥165.81 Million ≈ $24.26 Million	-23.77%
2009-12-31	CN¥217.51 Million ≈ $31.83 Million	-7.46%
2008-12-31	CN¥235.04 Million ≈ $34.39 Million	+8.32%
2007-12-31	CN¥216.99 Million ≈ $31.75 Million	-7.73%
2006-12-31	CN¥235.18 Million ≈ $34.41 Million	--

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$864.72 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9588 Global

#2419 in China

Share Price

CN¥3.04

Change (1 day)

-3.80%

52-Week Range

CN¥2.60 - CN¥4.15

All Time High

CN¥14.40